Prednisone Treatment for Vestibular Neuronitis

• Status: Completed
• Trial end date: 2007-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the study is to investigate the value of steroids in the treatment of vestibular neuronitis. The potential benefits of steroid therapy would be analyzed by the clinical response, self-perceived handicap and laboratory parameters.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Carmel Medical Center
• Collaborators: Clalit Health Services, Haifa and West Galilee; Hillel Yaffe Medical Center; Rambam Health Care Campus; University Health Network, Toronto
• Treatments: Prednisone

Criteria

Inclusion Criteria:

• Clinical diagnosis of vestibular neuronitis.

• Documentation of unilateral reduced caloric response (caloric asymmetry >25%) on the EOG caloric study.

Exclusion Criteria:

• Complaints of new hearing loss, tinnitus, or neurological deficits.

• The presence of previously non-diagnosed sensorineural hearing loss (SNHL)

• History of vestibular dysfunction.

• Patient younger than 18 years of age.

• Known contra-indication to systemic steroids: Unbalanced hypertension, un-controlled diabetes mellitus, immunodeficiency, active peptic disease, and avascular necrosis of the femoral head.